INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/14/2022
Back to search
Official data from USPTO
PRONOVA BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
PRONOVA BIOPHARMA
ST13
US500000079048576Class
5
Filing
79048576
Registration
3543855
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
01/14/2022
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/30/2007
Registration date
12/09/2008
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/26/2021
Last transaction
02/26/2021
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
NO
Examiner
TAYLOR, DAVID T
Law office
M30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
B. A. (pessoa física)
P. A. (pessoa física)
Representatives
Wendy E. Miller Cooper & Dunham LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in the treatment of metabolicinflammatory and cardiovascular diseases; lipids for pharmaceutical purposes for use in the treatment of metabolicinflammatory and cardiovascular diseases; substances with marine originOmega 3 lipids for pharmaceutical purposes used in the treatment of metabolicinflammatory and cardiovascular diseases
Publications
History of USPTO decisions and trademark events.
41 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
12/09/2021
INPC
INVALIDATION PROCESSED
12/09/2021
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/26/2021
C71T
CANCELLED SECTION 71
02/26/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/08/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
12/09/2017
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/16/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/27/2015
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
01/08/2015
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
01/08/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/08/2015
ES75
TEAS SECTION 71 & 15 RECEIVED
12/08/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/30/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/30/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/07/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/26/2009
FIMP
FINAL DISPOSITION PROCESSED
03/26/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/09/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2008
PUBO
PUBLISHED FOR OPPOSITION
09/23/2008
NPUB
NOTICE OF PUBLICATION
09/03/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/20/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/15/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/15/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/15/2008
ALIE
ASSIGNED TO LIE
08/15/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/29/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/29/2008
RFNT
REFUSAL PROCESSED BY IB
03/28/2008
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/05/2008
RFRR
REFUSAL PROCESSED BY MPU
03/05/2008
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/05/2008
CNRT
NON-FINAL ACTION WRITTEN
03/04/2008
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
02/20/2008
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/20/2008
CNRT
NON-FINAL ACTION WRITTEN
02/19/2008
DOCK
ASSIGNED TO EXAMINER
02/12/2008
NWAP
NEW APPLICATION ENTERED
02/08/2008
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/07/2008
Continuous trademark protection
Get notified about every new filing that threatens PRONOVA BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.